Background & Aims
Erythromelalgia (EM) is a descriptive term for a rare, chronic pain disorder involving an intense burning sensation, warmth, and erythema, usually affecting the distal extremities, typically worsened by heat and partially relieved by cold [1-3]. With an estimated incidence of 0.25-2 cases per 100,000 per year [4, 5], the rarity of the condition has led to few case series or outcomes studies on pediatric EM, and even fewer with long-term outcomes [3, 6, 7]. Therefore, the ultimate goal is to establish a multi-institutional and multi-disciplinary collaboration to gather retrospective and prospective data, via a registry/repository, on pediatric patients with EM. As initial steps to create this registry, we have set to (a) summarize the current literature on pediatric EM and (b) identify priorities for recognition and management from multiple stakeholders such as clinicians, people with lived experience of pediatric EM, and their family members.
Methods
The Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews Checklist was followed for the scoping review [8]. The priority setting project followed the James Lind Alliance Priority-Setting Process [9]. The top 10 research priorities will be identified through 4 phases: 1) An international online survey to gather priorities from stakeholders, including those with lived experience with pediatric erythromelalgia; 2) Data processing of the survey responses; 3) Interim prioritization through another online survey to targeted stakeholders to reduce the list of research questions to be discussed at the priority setting workshop; and 4) A consensus workshop to set the final priorities.
Results
To date, more than 60 individuals, spanning more than 30 institutions across the United States of America, Canada, Australia, and the United Kingdom, and multiple disciplines (anesthesiology, neurology, dermatology, rheumatology, genetics, psychology, nursing, biostatistics, translational research, etc.) were invited to partake in this collaboration. A steering committee of 13 multidisciplinary members, including a patient partner, was elected to drive the collaboration forward. For the scoping review, 3098 articles were imported from 5 online databases. Upon removal of duplicates, 1847 articles were screened leading to 731 full-text articles to be assessed for eligibility. 195 articles were included for data extraction. A collaboration with The Erythromelalgia Association is under discussion regarding the priority setting process.
Conclusions
Results from both of these projects will serve as a foundation for the registry to determine which common data elements will be collected from all institutions and determine which research questions on pediatric EM are priorities for clinicians, patients and their family members.
References
1.Parker, L.K., et al., Clinical features and management of erythromelalgia: long term follow-up of 46 cases. Clin Exp Rheumatol, 2017. 35(1): p. 80-84.
2.Tham, S.W. and M. Giles, Current pain management strategies for patients with erythromelalgia: a critical review. Journal of Pain Research, 2018. 11: p. 1689-1698.
3.Sun, J., et al., Clinical Characterization of Pediatric Erythromelalgia: A Single-Center Case Series. Children, 2023. 10(8): p. 1282.
4.Alhadad, et al., Erythromelalgia: Incidence and clinical experience in a single centre in Sweden. Vasa, 2012. 41(1): p. 43-48.
5.Reed, K.B. and M.D. Davis, Incidence of erythromelalgia: a population-based study in Olmsted County, Minnesota. J Eur Acad Dermatol Venereol, 2009. 23(1): p. 13-5.
6.Arthur, L., et al., Pediatric Erythromelalgia and SCN9A Mutations: Systematic Review and Single-Center Case Series. J Pediatr, 2019. 206: p. 217-224 e9.
7.Cook-Norris, R.H., et al., Pediatric erythromelalgia: a retrospective review of 32 cases evaluated at Mayo Clinic over a 37-year period. J Am Acad Dermatol, 2012. 66(3): p. 416-23.
8.Tricco, A.C., et al., PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med, 2018. 169(7): p. 467-473.
9.The James Lind Alliance Guidebook Version 10. 2021: The James Lind Alliance, The Wessex Institute, University of Southampton.
Presenting Author
Don Daniel Ocay
Poster Authors
Don Daniel Ocay
PhD
Boston Children's Hospital
Lead Author
Maria Graziano Maloney
BA
Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital
Lead Author
Genevieve D'Souza
Stanford University
Lead Author
Catherine Brownstein
PhD
Division of Genetics and Genomics, Department of Pediatrics, Boston Children’s Hospital
Lead Author
Jacqui Clinch
MRCP
Department of Pediatric Rheumatology, Bristol Royal Hospital for Children
Lead Author
Dawn Marie R. Davis
MD
Department of Dermatology and Pediatrics, Mayo Clinic Rochester
Lead Author
Deirdre De Ranieri
MD
Division of Rheumatology, Department of Pediatrics, Ann & Robert H. Lurie Children’s Hospital of
Lead Author
Carolina Donado
M.D.
Boston Children's Hospital
Lead Author
Meghan Halpin
BS
Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital
Lead Author
Benjamin Howard Lee
MD
Department of Anesthesiology, Emory University School of Medicine
Lead Author
Kimberly Lobo
MS
Boston Children's Hospital
Lead Author
Deepa Kattail
MD
Department of Anesthesia and Pain Medicine, The Hospital for Sick Children (SickKids)
Lead Author
Danielle Ravetti
The Erythromelalgia Association
Lead Author
Paola Sandroni
MD
Department of Neurology, Mayo Clinic Rochester
Lead Author
Jennifer Stinson
PhD
SickKids and University of Toronto
Lead Author
See Wan Tham
MD
Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine
Lead Author
Gary Walco
University of Washington School of Medicine
Lead Author
Suellen Walker
UCL GOS Institute of Child Health
Lead Author
Charles Berde
MD
Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital
Lead Author
Topics
- Informatics, Coding, and Pain Registries